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Abstract
Background: Endocrine disruptor chemicals elicit adverse health effects by perturbing nuclear receptor signalling systems.
It has been speculated that these compounds may also perturb epigenetic mechanisms and thus contribute to the early
origin of adult onset disease. We hypothesised that histone methylation may be a component of the epigenome that is
susceptible to perturbation. We used coexpression analysis of publicly available data to investigate the combinatorial
actions of nuclear receptors and genes involved in histone methylation in normal testis and when faced with endocrine
disruptor compounds.
Methodology/Principal Findings: The expression patterns of a set of genes were profiled across testis tissue in human, rat
and mouse, plus control and exposed samples from four toxicity experiments in the rat. Our results indicate that histone
methylation events are a more general component of nuclear receptor mediated transcriptional regulation in the testis than
previously appreciated. Coexpression patterns support the role of a gatekeeper mechanism involving the histone
methylation modifiers Kdm1, Prdm2, and Ehmt1 and indicate that this mechanism is a common determinant of
transcriptional integrity for genes critical to diverse physiological endpoints relevant to endocrine disruption. Coexpression
patterns following exposure to vinclozolin and dibutyl phthalate suggest that coactivity of the demethylase Kdm1 in
particular warrants further investigation in relation to endocrine disruptor mode of action.
Conclusions/Significance: This study provides proof of concept that a bioinformatics approach that profiles genes related
to a specific hypothesis across multiple biological settings can provide powerful insight into coregulatory activity that
would be difficult to discern at an individual experiment level or by traditional differential expression analysis methods.
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Introduction
Endocrine disruptors are a highly heterogeneous group of
compounds that range from synthetic chemicals and pesticides to
natural compounds found in foods [1]. Results from animal studies
have linked exposure to these compounds with adverse health
outcomes ranging from reproductive [2] and metabolic disorders
[3] to alterations in neuronal development [4]. Perturbation of
hormonal systems such as receptor binding, hormone production,
release, transport or elimination is well documented [1,5]. Less
well understood and of growing concern is the potential for these
compounds to perturb epigenetic mechanisms during embryogen-
esis and thus increase the risk of dysfunction and disease
susceptibility later in life.
The OECD (Organisation for Economic Co-operation and
Development) recently published a review entitled Endocrine
Disruptors and the Epigenome (available at www.oecd.org/dataoecd/
42/53/48435503.pdf). The authors state that evidence to date is
highly-suggestive of a role for epigenetic dysregulation in the
mediation of endocrine disruptor exposure effects. Consequently
the incorporation of epigenetic knowledge into chemical safety
assessment regulatory activity is now a major objective for the
OECD. This objective continues to be challenged by gaps in
knowledge surrounding the intersection of endocrinology and
epigenetic biology, see Zhang and Ho [6] and LeBaron [7] for
pertinent reviews.
Nuclear receptors are an integral component of transcription
regulation. The mechanisms that confer context specificity and
fine-tuning of nuclear-receptor mediated changes in gene
expression continue to be elucidated and are found to be
increasingly complex. In addition to the classical ligand mecha-
nism, ligand-independent action of receptors is reported [8]
together with the involvement of complexes of coactivators and
corepressors that encompass groups of molecules with a diverse
range of functional capacity. The work described here focuses on
the subset of coregulators that are associated with one specific
aspect of the epigenetic apparatus: the modification of histone
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sequential and combinatorial regulatory action of nuclear
receptors and histone methylation modifiers within the context
of transcriptional regulation.
Histone methylation plays a role in the establishment and
maintenance of long-term epigenetic marks such as X chromo-
some inactivation and imprinting [9] and also in chromatin
modification associated with temporal transcriptional changes
[10,11]. A role for histone methylation events has been described
in processes susceptible to endocrine disruption such as steroido-
genesis [12], spermatogenesis [13] and embryonic development
[11]. Functional studies that knock out or reduce the levels of
enzymes that modify histone methylation status describe pheno-
typic outcomes similar to those observed following exposure to
endocrine disruptor compounds [14]. Increasingly, reports in the
literature link histone methylation and nuclear receptor activity
[13,15–17]. Of particular interest are a gatekeeper mechanism
reported by Garcia-Bassets et al [18], whereby histone methylation
events prevent constitutive expression in the absence of ligand, and
nuclear receptor interaction with components of histone methyl-
ation modifying complexes - collectively referred to herein as
ASCOM (ASC-2 [activating signal cointegrator-2] complexes
[19–22]. The nuclear receptor interacting protein NCOA6 (also
named activating signal cointegrator-2 (ASC-2)), has been shown
in mammalian cells to complex with ASCOM and to act as a
linker protein between nuclear receptors and ASCOM compo-
nents [21]. Direct interaction between ASCOM components and
estrogen [22–24], progesterone [25] and peroxisome proliferator-
activated receptors [24,26] has also been reported. Together, this
evidence led us to hypothesise that histone methylation events may
be susceptible to perturbation by endocrine disruptor compounds
via their coregulatory activity with nuclear receptors. We
envisaged that publicly available gene transcription data could
be analysed to gain insight into coregulatory activity and
susceptibility of these mechanisms to compound exposure.
A limitation of transcriptomics is that only a snap shot is
captured of either perturbed or normal function. The common
toxicogenomics approach whereby pathways perturbed following
exposure are inferred by statistical enrichment of top differentially
expressed genes is not always optimal. Subtle changes in the levels
of mRNA for some genes may have strong biological consequence,
but may be missed or overshadowed by larger changes occurring
in the many genes affected at a whole genome level. Also, given
that functional investigations of the epigenome are recently
published, this aspect of biology is likely to be currently under-
represented in the gene ontology annotations commonly used as a
basis for enrichment analysis. Furthermore, given the temporality
of histone methylation events and the interdependency of genes
within coregulatory complexes, analysis of changes in simple
binary associations following exposure is likely to be misleading.
With these limitations in mind we opted to predefine an analysis
geneset enriched for our study objectives and profile both
expression and coexpression within this geneset in a range of
normal and exposure settings.
The intersection between nuclear receptor activity and the
histone methylation aspect of the epigenetic apparatus has several
implications for endocrine disruptor mode of action. Firstly there is
the possibility that compound-induced alteration of histone
methylation activity is a common contributing factor to the
dysregulation of genes with diverse phenotypic outcomes and thus
an explanatory factor in multiple phenotypic outcomes from
exposure to a single compound. The estrogenic endocrine
disruptor diethylstilbestrol is a case in point where exposure in
animal studies has been associated with a range of cancers,
malformation of the genital track, obesity [27] and at a molecular
level changes in DNA methylation [28]. Secondly there are
implications for direct or indirect long-term effects arising from
epimutations or aberrant epigenetic function. Consider, for
example, the dysregulation of genes on the steroidogenic pathway
following in utero exposure to some phthalates. This temporal
perturbation indirectly contributes in part to malformations in
offspring through disruption of hormonal activity at critical
developmental time points [5]. From an epigenetic perspective,
it is feasible that compound exposure elicits similar temporal
effects in histone methylation balance that indirectly result in long-
term effects. Alternatively exposure may give rise to permanent
aberrant methylation marks that alter the response of affected
genes to future environmental stimuli and thus increase suscep-
tibility to dysfunction or disease later in life. The rationale behind
the current investigation is that both short-term, indirect long-term
and direct long-term effects might share a common etiology that
involves, in part, nuclear-receptor mediated changes in histone
methylation status.
We used publicly available expression data to appraise whether
and to what extent nuclear receptors show coexpression with genes
involved in histone methylation modification in testis tissue across
a range of biological settings including species, development stage
and following exposure. In regards to exposure it should be
clarified that the objective of the study was not to identify
correlation between compound-specific exposure and coexpression
patterns as this would require alternative study designs. Rather,
our objective was to identify coexpression patterns that support the
concept of nuclear receptor coactivity with histone methylation
modifying genes. The rationale being that these mechanisms
represent a pathway between nuclear receptor action and the
modification of developmentally critical epigenetic marks and such
mechanisms could provide insight into aspects of endocrine
disruption that remain enigmatic.
Similar coexpression patterns between specific nuclear receptors
and histone methylation modifiers in testis tissue from different
species and across experiments were observed, strengthening the
evidence for coactivity and or interdependence between these two
distinct functional gene groups. Importantly, our results are a
proof of concept that profiling a set of genes related to a specific
hypothesis across multiple biological settings can identify patterns
of coregulatory dynamics that are difficult to discern at an
individual experiment level. These patterns provide a framework
against which endocrine disruption can be best analysed and
better understood.
Results
In silico validation of enriched geneset
As detailed in Methods and Table S1, the enriched geneset
consisted of groups of genes belonging to the nuclear receptor
family, histone methylation modifiers and genes key to endocrine
disruption phenotypes. As an additional validation technique, we
analysed our selected geneset to verify that the members show
enrichment for our hypothesis. We performed canonical pathway
enrichment as implemented in the Ingenuity Pathway Analysis
(IPA) software (Ingenuity Systems, www.ingenuity.com). Results
from this analysis confirmed that 74% (102/137) of the genes in
the analysis set were functionally associated with transcriptional
regulation. Physiological systems identified by canonical pathway
enrichment included endocrine system development and function
(31 genes), embryonic development (62 genes) and regulation of
development (81 genes).
Potential Endocrine Disruption of the Epigenome
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Coexpression analysis between nuclear receptors and histone
methylation modifiers in testis tissue across multiple experiments
provided insight into the generality of their coactivity: all of the
nuclear receptors (n=41) were observed to show strong coexpres-
sion (Pearson r$0.75 or #20.75, p-value,0.05) with one or more
histone methylation modifiers in the normal testis tissue of one or
more species. Coexpression relationships of similar strength
involving 12 nuclear receptors, 16 methyltransferases and three
demethylases, were observed in all three species from Experiment
1, see Table S2 A. 21% (90/421) of the coexpression relationships
observed in rat testis of this experiment were also observed with
similar strength and direction in one or more of the spermatocyte
or round spermatid samples from Experiment 10. Across the seven
studies in rat 62 coexpression relationships involving 23 nuclear
receptors and 35 histone methylation modifiers were observed
three or more times in normal tissue samples Most represented in
this group were the nuclear receptors Nr2c1 (26 occurrences),
Nr3c1 (16 occurrences) the demethylases Kdm3a (13 occurrences)
and Kdm1 (12 occurrences) and the methyltransferases Cxxc1 (13
occurrences) and Setdb1 (12 occurrences).
Experiment 7 samples represented embryonic tissue collected
from the efferent ducts, epididymis and vas deferens. Correlated
expression of similar strength and direction between the nuclear
receptor Rarb and the methyltransferase Suv39h1 and the nuclear
receptor Nr1h2 and the methyltransferase Suv420h2 was observed
in all three of these tissues. A further 49 coexpression relationships
were observed in two of the three tissues, see Table S3 A. Results
from Experiment 7, 8 and 9, which represent tissues from whole
testis, revealed 115 coexpression relationships to be conserved
across all embryonic mouse tissue, see Table S3 B. Most
represented in this group were the nuclear receptors Ppard (25
occurrences) and Nr4a2 (18 occurrences), the demethylase Kdm2b
(9 occurrences) and the methyltransferase Ehmt2 (19 occurrences).
Comparison between embryonic and adult tissue in mouse
revealed 47 conserved coexpression relationships and only 18
coexpression relationships were conserved between mouse and rat
embryonic tissue.
The observation of similar coexpression patterns between
specific nuclear receptors and histone methylation modifiers in
testis tissue from different species and across experiments
strengthens the evidence for coactivity and or interdependence
between these two distinct functional gene groups.
ASCOM (Activating Signal Cointegrator-2 complex)
ASCOM represents a pool of complexes – each of which
contain an evolutionarily conserved core – comprising the WD
repeat domain 5 (WDR5) protein, the ASH2-like protein (ASH2L)
and the retinoblastoma binding protein 5 (RBBP5) and one or
more additional methyltransferase with specificity for the H3K4
substrate [21]. The methyltransferases MLL1 to MLL5, MEN1,
CXXC1, PAXIP1, DPY30 and the demethylases KDM6A and
KDM6B have also been reported as components of ASCOM and
ASCOM like histone methylation modifier complexes. Coactivity
of these proteins was reflected in our IPA network analysis, see
Figure S1. The functional relevance of these complexes in testis
tissue is yet to be explored. Here, genes encoding these proteins
were found to have strongly correlated expression patterns in the
testis tissue of all three species, see Figure 1. The protein
transcribed from Ncoa6 is considered to act as an integrator
between nuclear receptors and ASCOM complexes. 85% (35/41)
of the receptors in the analysis geneset showed correlated
expression with Ncoa6 across the group of all normal samples. In
grouped exposed samples 73% (30/41) showed correlated
expression with Ncoa6 and 18 of the nuclear receptors were
common to both groups.
Ncoa6 showed strong coexpression with all ASCOM compo-
nents with the exception of Mll3 and Mll4 in both normal and
exposed tissue, eight of the coexpression relationships were
observed in three or more sample sets. These results indicate that
recruitment of the ASCOM complex is a more general component
of nuclear receptor mediated transcriptional regulation in the testis
than previously appreciated.
Gatekeeper mechanism
Garcia-Bassets et al [18] identified a role for histone
modification as a gatekeeper mechanism that acts to either
facilitate promoter access to liganded-nuclear receptors or to
prevent access and thus constitutive recruitment of receptors to
promoters in the absence of ligand. Specifically, they showed that,
in the presence of liganded-receptors, recruitment of the
demethylase KDM1 to the promoter of some estrogen receptor
target genes was required to remove repressive marks conferred by
the methyltransferases EHMT1, PRDM2 and ESET (also known
as SETDB1). To identify a potential role for this mechanism in
endocrine function in the testis, we profiled expression patterns
Figure 1. Coexpression patterns in human, mouse and rat testis. Coexpression between ASCOM genes in rat human and mouse are
represented as networks. Green octagons=methyltransferases and purple vee=histone demethylases. Edge labels represent Pearson correlation
significant at p,0.05.
doi:10.1371/journal.pone.0034158.g001
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identified by Garcia-Bassets et al, and genes in our analysis set that
were relevant to endocrine disruptor phenotypes. In the rat data,
both estrogen receptors showed coexpression with Ehmt1 and
Prdm2, and Esr1 was negatively coexpressed with Kdm1.A
consistent pattern between the estrogen receptors, the methylation
modifiers and 64% (14/22) of the phenotypic genes was also
observed. In human samples, only the estrogen receptor alpha
(Esr1) showed coexpression with the gatekeeper genes and a similar
pattern of coexpression with nine phenotypic genes was observed.
An interesting pattern was observed in the mouse data whereby
only one gatekeeper gene Ehmt1 showed coexpression with Esr1
and this relationship was reflected in the coexpression patterns of
ten phenotypic genes. Together these patterns support the concept
of a gatekeeper mechanism involving Esr1 and histone methylation
modifiers in testis tissue. Figure 2 provides a visual representation
of these coexpression patterns whereby the coexpression between
genes involved in the gatekeeper mechanism are shown as a
network and the strength of coexpression of these genes with each
phenotypic gene is represented in a bar graph.
The reflection of nuclear receptor histone methylation coex-
pression patterns in the coexpression patterns of phenotypic genes
was evidenced in several of the data sets. A clear example was
observed in data from Experiment 6. This dataset contained
samples obtained from controls and from rats exposed from
gestational day six to postnatal day 92 to low and high dose
myclobutanil, low and high dose propiconazole and low and high
dose triadimefon. The observed pattern involved the Ar and Esr2
receptors, the methyltransferases Ehmt2, Ehmt1, Prdm2 and Setdb1
and the demethylase Kdm1. The pattern is best understood as
having two components the first of which represents the
coexpression profile of the coregulatory genes, henceforth referred
to as the gatekeeper set (Esr2, Ehmt2, Ehmt1, Kdm1, Prdm2 and Setdb1).
The second component represents the coexpression between
phenotypic genes and genes in the gatekeeper set. In samples that
had been exposed to high dose triadimefon, the gatekeeper set
were found to have highly correlated expression patterns, shown as
a network in Figure 3. In the same samples, of the 22 phenotypic
genes in the analysis geneset, nine did not show coexpression with
either Ar or Esr2, three had coexpression approaching significance
with Esr2 and 10 had strong coexpression with Esr2, Ar or both. In
the latter group the 10 phenotypic genes also showed strong
coexpression with the remaining members of the gatekeeper set in
a consistent pattern of correlation or anti-correlation, see Figure 3
bar graph. Phenotypic genes with coexpression approaching
significance showed a similar pattern with the gatekeeper set
genes that was also approaching significance and genes found not
to have correlated expression with either of the nuclear receptors
showed no correlated expression with any of the gatekeeper genes.
By comparison, in samples exposed to low levels of propicona-
zole only two of the gatekeeper genes showed high coexpression
with each other and none showed coexpression with a nuclear
receptor. In these samples none of the 22 phenotypic genes
showed coexpression with any components of the gatekeeper
geneset.
These patterns observed in Experiment 6 further support the
concept of the gatekeeper mechanism whereby histone methyla-
tion modifiers work in concert with nuclear receptors to mediate
transcriptional change at target genes. The observation of such
patterns in both normal and exposed tissue indicate that this
coactivity is not specific to either normal function or exposure
response but likely represents a more general component of
transcriptional regulation. From the perspective of endocrine
disruption the main point of interest is that gatekeeper type
mechanisms may represent a common regulatory mechanism for
genes with diverse functional roles and thus a potential
explanatory factor for compound exposure that elicits multiple
phenotypic outcomes.
ASCOM coexpression patterns in controls and exposed
samples
In the data from experiments 2–4, which all involved in utero
exposure, Ncoa6 was observed to have correlated expression with a
higher number of genes in the analysis geneset in exposed samples
(n=62) as compared to controls (n=21). This suggests that
recruitment and activity of ASCOM and other transcriptional
regulatory complexes associated with Ncoa6 increases overall
following in utero compound exposure. The specific actions of
histone methylation modifiers is determined, in part, by the
proteins they complex with, so while the number of genes Ncoa6
showed correlated expression with was similar in both controls
(n=9) and exposed (n=8) samples in the adult exposure setting of
Experiment 5, the function of the coexpressed genes suggest that
different transcriptional outcomes would have been elicited. In the
control samples, Ncoa6 showed strong coexpression with ASCOM
methyltransferases that confer marks associated with transcrip-
tional activity (Mll1 r=0.89, Mll4 r=0.89, Mll5 r=0.90), while in
exposed samples positive coexpression with the corepressors Hdac2
(r=0.90) and Ncor2 (r=0.91) was observed.
Wdr5 is a core structural component of ASCOM which plays a
critical role in substrate recognition and bridging of catalytic
components to the histone tail [29,30]. We found increased
correlation of this gene in the group of exposed samples (n=168)
(n=57) as compared to the group of controls (n=21) (n=56) from
the same experiments. An increase in coexpression between Wrd5
and other methyltransferases indicates overall global changes in
histone methylation. Resulting transcriptional outcomes would be
substrate and target gene specific.
Interestingly, in control samples of Experiment 3 Wdr5 showed
strong coexpression with the gatekeeper gene Prdm2 (r=0.98),
which confers a silencing mark, and was not observed to have
coexpression with any other ASCOM components in this setting.
In contrast, when strongly coexpressed with the gatekeeper
activator Kdm1 in exposed (dibutyl phthalate) samples from the
same experiment (r=0.99), vinclozolin exposed samples from
experiment 2 (r=0.93) and a coexpression relationship approach-
ing significance in dibutyl phthalate exposed samples from
experiment 4 (r=0.94, p=0.06), correlated expression with one
or more ASCOM components was observed. In each of these
exposure settings simultaneous coexpression with an estrogen
receptor was also observed.
A similar pattern was observed in Experiment 6. Wdr5 showed
correlated expression with the highest number of ASCOM
components in the samples exposed to high levels of triadimefon
(n=11) in comparison to the five other exposure settings (n=0 or
1) and controls (n=4). Wdr5 also showed correlated coexpression
with Kdm1 and anti-correlated expression with Esr2 in both the
control and high triadimefon exposure settings and in the latter
strong anti-correlation with Prdm2 was also observed.
In addition to its role in the gatekeeper mechanism Kdm1 is
implicated in coactivation of the androgen receptor via modifica-
tion of H3K9me2/me1 [16]. In Experiment 3 the androgen
receptor showed positive coexpression with Kdm1 (r=0.97) and
coexpression approaching significance with Wdr5 (r=0.95,
p=0.05), see Figure 4.
Observed coexpression between the gatekeeper gene Kdm1 and
core ASCOM component Wdr5 in multiple settings suggest that
these mechanisms act in concert to confer nuclear receptor
Potential Endocrine Disruption of the Epigenome
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genes and androgen and estrogen receptors in multiple settings
indicate that their coactivity is a potential point of convergence
between estrogen and androgen signalling pathways. Changes in
their coexpression patterns following exposure suggest a role in
toxicity response, however given the temporality of histone
methylation events it cannot be discerned from these patterns
alone as to whether these changes represent normal or aberrant
function.
A role for the gatekeeper and ASCOM complexes in Star
gene dysregulation
Perturbation of the steroidogenic pathway is a known mode of
action for several endocrine disruptor compounds [5]. The
steroidogenic acute regulatory protein StAR is the rate limiting
protein in steroidogenesis and epigenetic regulation of this gene
has been previously described by Hiroi et al [12]. This work
provides a background against which changes in coexpression
observed in the current study can be best interpreted. Hiroi et al
describe multiple substrate and gene loci specific alterations to
histone marks during and following hormone induced transcrip-
tional changes. In particular, they noted a reduction in the
repressive mark H3K9me2, initially in the promoter region and
then in the coding region of the Star gene, that was associated with
hormone-induced increased transcription in MA-10 and mouse
granulose cells. Here, coexpression patterns between the Star gene
and histone methylation modifiers varied across settings and
between control and exposed samples. Common to more than one
exposure setting, however, were changes in coexpression with the
gatekeeper methyltransferase Prdm2 which has specificity for
H3K9me2. This gene was observed to have negative correlation
with the Star gene in both in utero exposures (vinclozolin r=20.87,
dibutyl phthalate r=20.95) and a negative correlation approach-
Figure 2. Gatekeeper gene coexpression patterns across species. Coexpression between genes implicated in the gatekeeper mechanism
described by Garcia_Bassets et al are represented as networks. Pink ellipses=nuclear receptors, yellow=histone methyltransferases and blue
vee=histone demethylase. Edge labels=Pearson correlation significant at p,0.05. These coexpression relationships are reflected in the coexpression
patterns between gatekeeper genes and genes relevant to endocrine disruptor phenotypes and the methyltransferase Dnmt1, shown in associated
bar graphs for rat, human and mouse Bar lengths represent Pearson correlation, positive values=positive correlation and negative values=inverse
correlation, significant at p,0.05. Genes relevant to endocrine disruptor phenotypes: sexual differentiation (Bmp7, Bmp8a, Dmrt1, Dmrt2, Dmrt3,
Dmrta1, Fgf9, Jag2, Shh, Sry); embryonic development (Bmp4, Hoxa4, Hoxa10, Hoxa11, Hoxd3, Hoxd8); obesity (Lep, Lepr, Leprot); spermatogenesis
(Prm1, Prm2) and steroidogenesis (Star).
doi:10.1371/journal.pone.0034158.g002
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exposed to dibutyl phthalate (r=20.84, p=0.075) at age10 weeks.
The ASCOM component Men1 was observed to have correlated
expression with the Star gene in control samples collected at
gestational day 20 (r=20.99) from Experiment 3, control samples
collected at embryonic day 16 (r=0.99) from Experiment 2 and in
the normal samples of experiment 1 (r=0.87). Men1 confers the
H3K4me3 mark associated with gene activation and has recently
been linked to estrogen dependent coactivation [31]. Loss of
correlated expression between this gene and the Star gene in
exposed samples may be a contributing factor to dysregulation of
Star expression. The coexpression patterns observed between
Prdm2 and Men1 with the Star gene, observed in multiple studies,
further suggest that the gatekeeper and ASCOM complexes work
in concert as estrogen receptor mediated transcriptional regula-
tors.
Dnmt1 and the gatekeeper mechanism
The DNA (cytosine-5-)-methyltransferase Dnmt1 has been
observed to influence the ratio of H3K4me2/H3k9me2 [32] in
addition to its role as a cytosine methyltransferase. Here, Dnmt1
showed the same coexpression pattern with the gatekeeper genes
as was observed with phenotypic genes in normal tissue samples
from Experiment 1, see Figure 2. These patterns indicate a role for
the gatekeeper mechanism in transcriptional regulation of Dnmt1
in the testis.
Kdm1 and Dnmt1coexpression patterns
Kdm1 has been previously reported to demethylate and stabilise
Dnmt1, and is purported to act as a link between the histone and
DNA methylation systems [33]. In the vinclozolin experiment
Kdm1 and Dnmt1 were strongly correlated and showed similar
changes in coexpression patterns following exposure. Both genes
had increased coexpression with transcriptional modifiers in
exposed samples (Kdm1 n=41, Dnmt1 n=42) as compared to
controls (Kdm1 n=2,Dnmt1 n=11). Common to the coexpression
hubs of Kdm1 and Dnmt1 in exposed samples were 38 relationships
involving core and catalytic components of the ASCOM complex
and nine nuclear receptors including both estrogen receptors,
Nr5a1 (also known as steroidogenic factor SF-1) and Nr2c2, which
is required for normal spermatogenesis and early embryonic
development, see Figure 4
The coexpression patterns observed in the vinclozolin data
indicate that multiple nuclear receptors and histone methylation
modifiers act in concert and their coactivity has the potential to
influence both histone and DNA epigenetic marks.
Differential expression
Differential expression of all genes in the analysis geneset
showed very few genes to be dysregulated in each experiment at
the study cut-off limits. Of all the exposure settings of Experiment
6, only the high dose triadimefon showed dysregulation and only
modest fold changes for two genes (Cyp17a1 and Insl3) which were
not significant after adjusting for multiple testing. No histone
methylation modifying genes were observed to be dysregulated in
dibutyl phthalate Experiments 3–5. In Experiment 3, comparison
between controls and vinclozolin exposed samples for each
generation (controls n=2, exposed n=2) showed the demethylase
Kdm6b to be down-regulated at each generation and the
gatekeeper gene Ehmt1 showed statistically significant down-
regulation in each generation but just below the study cut-off
value of a 1.5 fold change. When the samples were grouped and
analysed as controls (n=6) versus vinclozolin exposed (n=6),
differential expression of methylation modifiers and nuclear
receptors was more evident, see Tables 1 and 2, however
differential expression patterns did not reflect the changes
observed in the coexpression analysis. These results indicate that
histone methylation events and changes in the complex dynamics
Figure 3. Gatekeeper gene coexpression patterns from Experiment 6. A: Coexpression between genes implicated in the gatekeeper
mechanism identified by Garcia- Bassets et al are represented as a network. Pink ellipses=nuclear receptors, yellow and olive green=histone
methyltransferases and blue vee=histone demethylase. Edge labels=Pearson correlation significant at p,0.05. 3.B: The coexpression relationships
in 3.A are reflected in the coexpression patterns between gatekeeper genes and genes relevant to endocrine disruptor phenotypes: sexual
differentiation (Dmrt1, Dmrta1, Fgf9, Shh, Insl3); embryonic development (Hoxa10), steroidogenesis (Cyp17a1, Star);obesity (Leprot) and
spermatogenesis (Prm2).
doi:10.1371/journal.pone.0034158.g003
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34158Figure 4. Coexpression between gatekeeper genes and ASCOM component Wdr5. Coexpression patterns observed in both controls and
exposed samples support a role for a gatekeeper mechanism. Given the dynamic nature of histone methylation, perturbation cannot be inferred from
differences between control and exposed groups. More in-depth studies are warranted to investigate exposure effects on these mechanisms. A: In
control samples from Experiment 2 Kdm1 was observed to have coexpression higher than the study cut-off limits with only three other histone
modifiers including the gatekeeper genes Ehmt1 and Prdm2(approaching significance), and no nuclear receptors. In contrast, in samples from the
same experiment that are derived from decedents of an F0 vinclozolin exposed dam, Kdm1 showed strong coexpression with Esr2, multiple other
nuclear receptors and histone modifiers including the core ASCOM component Wdr5 and the methyltransferase Dnmt1. B: In Experiments 3 and 4
Wdr5 is anti-correlated with Esr1 and has correlated expression with Kdm1. In control samples of Experiment 3 Wdr5 shows coexpression approaching
significance with Esr1 (p=0.06) and the gatekeeper gene Prdm2. In Experiment 4 only one gatekeeper gene Ehmt1 shows coexpression with Wdr5. C:
Potential Endocrine Disruption of the Epigenome
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that would be difficult to detect in studies with low sample
numbers.
Discussion
Recent reviews in the literature describe a critical role for
histone methylation marks as determinants of transcriptional
potential at the centre of cellular differentiation, long-term
epigenetic programming, cellular homeostasis and pathogenesis
[9,11,12,19,34]. Functional studies have identified coactivity
between histone methylation modifiers and nuclear receptors but
a role for these coregulatory dynamics in testis is yet to be fully
elucidated. The activity of enzymes that confer histone methyla-
tion events is dynamic, highly context specific and varies according
to the coregulatory proteins, including nuclear receptors, that they
interact or complex with. Given the temporality and variability in
natural function identifying perturbation following exposure is
particularly challenging. Here, we trialled a targeted approach
whereby the coexpression patterns of a subset of pertinent genes
was profiled across testis tissue from a range of biological settings.
The coexpression patterns in normal testis tissue provided insight
into the generality of coactivity between nuclear receptors and
histone methylation modifiers. These data support a role for two
specific transcriptional regulatory systems: the gatekeeper mech-
anism described by Garcia-Bassets et al and recruitment of
ASCOM histone modifier complexes.
Histone methylation modification as both unifying
determinant and delineator of endocrine disruption
Endocrine disruptor compounds are reported to elicit a wide
range of phenotypic outcomes that are associated with perturba-
tion of nuclear receptor signalling pathways but cannot be
adequately explained by this mode of action alone. The coactivity
of genes involved in the previously described gatekeeper
mechanism, as evidenced in coexpression patterns in the current
study, indicate that the gatekeeper concept is common to key
genes representing disparate endocrine disruptor phenotypes.
Common coexpression patterns with gatekeeper genes in all three
species were observed for the protamines Prm1 and Prm2 that are
essential for chromatin compaction during spermatogenesis, the
Lep gene which is associated with obesity, the steroidogenic Star
gene and genes relevant to sexual differentiation and embryogen-
esis. The research group that identified and described the
gatekeeper mechanism also noted that different estrogen receptor
target genes are regulated by alternative combinations of histone
demethylases and methyltransferases and concluded, as have
others, that modification of histone methylation ratios at distinct
substrates and gene loci is likely to be a general component of
transcriptional regulation. The coexpression patterns observed in
the current study further support this concept and indicate that
specific combinations of receptors and histone modifiers are
promising biomarkers that can discriminate between normal
function, exposure response and specific modes of perturbation.
Furthermore, identification of common combinations of coactiva-
tors and corepressor complexes across biological settings could
provide a framework for the principled extrapolation of results
across tissue and species, which is an unavoidable and major
challenge for health risk assessors.
Gaining insight into the enigmatic aspects of endocrine
disruption
Temporally and spatially inappropriate histone methylation
events following exposure could alter long-term transcriptional
trajectories and developmental programs via two main modes of
In Experiment 6 Wdr5 showed similar coexpression with Esr2, Ehmt2 and Kdm1 in both control and exposed samples and with additional gatekeeper
genes in the exposed group. Pink ellipses=nuclear receptors, green=histone methyltransferase and blue=histone demethylase. Edges represent
Pearson correlation; some of these relationships were approaching significance as indicated by the associated p-values.
doi:10.1371/journal.pone.0034158.g004
Table 1. Genes down-regulated in F1–F3 generation
following vinclozolin exposure, adjusted p-value,0.05.
Gene
Symbol Description Fold change
F1 control v F1 exposed
Kdm6b lysine (K)-specific demethylase 6B 1.79
Rora RAR-related orphan receptor A 1.61
Nr1h2 nuclear receptor subfamily 1, group H, member 2 1.6
Dnmt3b DNA (cytsine-5-)-methyltransferase 3 beta 1.53
Baz2a bromodomain adjacent to zinc finger domain 2A 1.5
Ehmt1 euchromatic histone-lysine N-methyltransferase 1 1.4
F2 control v F2 exposed
Kdm6b lysine (K)-specific demethylase 6B 1.99
Nr2f2 nuclear receptor subfamily 2, group F, member 2 1.65
Ehmt1 euchromatic histone-lysine N-methyltransferase 1 1.4
F3 control v F3 exposed
Kdm6b lysine (K)-specific demethylase 6B 2.03
Ehmt1 euchromatic histone-lysine N-methyltransferase 1 1.42
doi:10.1371/journal.pone.0034158.t001
Table 2. Genes down-regulated in grouped controls v
grouped exposed samples following vinclozolin exposure,
adjusted p-value,0.05.
Gene
symbol Description Fold change
Kdm6b lysine (K)-specific demethylase 6B 7.06
Nr1d2 nuclear receptor subfamily 1, group D, member 2 3.81
Kdm5b lysine (K)-specific demethylase 5B 3.76
Rora RAR-related orphan receptor A 3.14
Nr2f2 nuclear receptor subfamily 2, group F, member 2 2.93
Baz2a bromodomain adjacent to zinc finger domain 2A 2.66
Ehmt1 nuclear receptor subfamily 1, group H, member 2 2.58
Nr1h2 nuclear receptor subfamily 1, group H, member 2 2.57
Rara retinoic acid receptor, alpha 2.43
Dnmt1 DNA (cytosine-5-)-methyltransferase 1 2.43
Dnmt3b DNA (cytosine-5-)-methyltransferase 3 beta 2.27
Nr5a2 nuclear receptor subfamily 5, group A, member 2 2.25
Men1 multiple endocrine neoplasia 1 (menin) 2.18
Ehmt2 euchromatic histone-lysine N-methyltransferase 2 2.13
doi:10.1371/journal.pone.0034158.t002
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H3K27me3 and DNA methylation; or temporary transcriptional
perturbation of key genes at critical developmental time points by
competing with or altering histone methylation events triggered by
normal signalling pathways. Subtle perturbation of histone
methylation mark ratios in particular could explain some of the
enigmatic features of endocrine disruption such as transgenera-
tional effects and cumulative effects of compounds with disparate
modes of action.
Transgenerational effects
It has recently been shown that mature human spermatozoa
retain epigenetic marks such as H3K27 tri-methylation and H3K4
di-methylation at regulatory regions of genes that influence gene
expression during male and female gametogenesis and in
preimplantation embryos [35]. This research showed that H3K4
di-methylation was associated with low DNA methylation state
and, in general, histone marks and DNA methylation – which is
required for paternal imprinting in the next generation – were
observed to be mutually exclusive [35]. The ASCOM complexes
show specificity for the H3K4 and H3K27 substrates. Coactivity
between nuclear receptors and ASCOM components, as evi-
denced by coexpression patterns in this study, suggest a link
between hormonal signalling systems with the mechanisms that
establish histone methylation marks that are critical to the integrity
of epigenetic information passed from one generation to the next.
These results indicate that further investigation of nuclear-receptor
coactivity with the ASCOM complexes might provide useful
insight into transgenerational toxicity modes of action and these
mechanisms should be a focus of endocrine disruptor research.
Cumulative exposure investigations
Compounds that act by disparate mechanisms of toxicity have
demonstrated cumulative dose-additive effects despite their mode
of action differences [36]. Perturbation of coregulatory dynamics
involving nuclear receptors and histone methylation modification
may be a common factor, whereby the target genes being
regulated and associated with the compounds’ modes of action
may differ, but the underlying mechanism, i.e. perturbation of the
delicate balance between the actions of histone methyltransferases
and demethylases, is the factor compounded by their combinato-
rial effects. Following exposure, small fold changes in mRNA levels
of genes encoding histone modifying enzymes would likely be
difficult to detect in studies with small sample numbers. Their role
in toxicity modes of action and potential cumulative effects may
thus be easily overlooked.
The coexpression patterns observed in testis tissue across
multiple biological settings in this study concur with current
understanding of nuclear receptor activity, whereby receptors act
in concert with multiple sub-unit complexes of proteins. The
identification of which combinations of coregulatory networks are
specific to one or more nuclear receptors and the generality or
specificity of their coactivity in the testis is a knowledge-gap that
needs to be addressed. The incorporation of such information into
algorithms for the prediction of cumulative effects would likely
improve results.
Future studies
This study was restricted by the availability of appropriate data
sets in the public corpus and suitable probes on the associated
microarray platforms. Studies targeting appropriate cell lines and
tissues and specific endocrine disruptors would likely yield more
powerful results. Sufficient replicate samples to allow meaningful
correlation analysis may be more attainable as the cost of the
associated technology reduces over time. This study does,
however, provide proof of concept that profiling genes related to
a specific hypothesis across multiple biological settings can identify
patterns of transcriptional regulation that cannot be evidenced at a
single experiment level. These patterns provide a framework
against which endocrine disruption can be better understood and
assessed. On a broader level, the application of bioinformatics
approaches that integrate both methods and multiple data sources
has enormous potential to address the complexities inherent in
assessing health risk from potential epigenetic toxicants.
Conclusions
To the best of our knowledge this is the first study to attempt to
assess the generality of coregulatory action between nuclear
receptors and genes involved in histone methylation across species
and studies, and the susceptibility of their coregulator activity to
endocrine disruptors. Our results suggest that the gatekeeper
mechanism as described by Garcia-Bassets et al and activity of the
ASCOM histone methylation modifying complexes are an integral
component of nuclear receptor mediated transcriptional regula-
tion in the testis. Genes implicated in these transcriptional
mechanisms show common expression patterns with genes key
to multiple endocrine disruptor phenotypes and are thus a likely
common factor influencing dysregulation following exposure.
Given the tight context specificity of binding partners and target
substrates, coexpression patterns of distinct combinations of
nuclear receptors, histone demethylases and methyltransferases
have potential as biomarkers of both normal function and
endocrine disruption that warrants further investigation. Most
importantly, this work demonstrates that an integrative, multi-
experiment approach is required to gain perspective and further
understanding of both natural function and potential perturbation
of the epigenetic apparatus.
Materials and Methods
Analysis geneset
Genes from three main functional groups were considered to be
relevant to our hypothesis: nuclear receptors, histone methylation
modifiers and genes associated with endocrine disruptor pheno-
types. Nuclear receptors (n=41) were obtained from a review
paper on their nomenclature and function [37]. Histone modifiers
associated with demethylation (n=18), and methylation (n=45)
were obtained from reviews by Cloos [9] and Hublitz [11] and a
gene ontology search conducted in June 2011. Genes relevant to
nuclear receptor coregulation (n=7) and to endocrine disruptor
phenotypes (n=28) were selected from a literature review
conducted in the Web of ScienceH, see Table S1 for references
and details.
Gene expression data
Raw data were obtained from the European Bioinformatics
Institute (EBI) ArrayExpress repository, accession numbers E-
TABM-130, E-GEOD-10919, E-GEOD-25196, E-GEOD-13550,
E-GEOD-20952, E-GEOD-10412, E-GEOD-22616, E-GEOD-
18211, E-GEOD-6881 and E-GEOD- 29963. Experiments were
selected for their relevance to endocrine disruption and availability
of unprocessed array files and are summarised in Table S4.
Experiment 1, E-TABM-130, provided sufficient sample numbers
to conduct coexpression analysis in a tissue relevant to endocrine
disruption across three species. Samples selected from this data set
included 8 human, 12 mouse and 12 rat seminiferous tubules, total
testis, spermatocytes and spermatid cells pooled from several
juvenile or adult individuals. The study samples had been
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Plus 2.0, Affymetrix GeneChip Mouse Genome 430 2.0 and
Affymetrix GeneChip Rat Genome 230 2.0 platforms respectively.
Experiment 2, E-GEOD-10919, provided 12 testis samples from a
vinclozolin exposure experiment conducted over three genera-
tions. Samples had been collected at embryonic day 16 and
included 2 controls and 2 vinclozolin exposed for each of F1
through to F3 generations. Experiment 3, E-GEOD-25196,
provided samples from controls and rats exposed in utero to the
known endocrine disruptor dibutyl phthalate daily from gesta-
tional day (GD) 12 to 20. Samples from exposed testis had been
collected 6 hours following the final dose. Samples from
Experiment 4, E-GEOD-13550, were obtained from rats exposed
in utero to dibutyl phthalate or a control vehicle from gestational
day 12 to 20 (as per Experiment 3), but these samples were not
collected until post natal day 35. Samples selected from
Experiment 5, E-GEOD-20952, included five controls and five
samples from rats exposed to a single dose of dibutyl phthalate at
10 week of age. Experiments involving exposure to dibutyl
Phthalate were selected because this compound had known
endocrine disruptor properties. Experiment 6, E-GEOD-10412
provided samples from a toxicogenomics study involving three
triazole compounds. This dataset was selected to gain insight into
the profile of the genes of interest following exposure to a group of
similar chemicals. Experiment 7, E-GEOD-226616 provided
samples from three testis tissues in the mouse (efferent ducts,
epididymis and vas deferens) and was selected to allow profiling of
the geneset in different tissues of the testis. Mouse embryonic testis
tissue from Experiment 8, E-GEOD-18211, and Experiment 9, E-
GEOD-18211, were selected to allow comparison between mouse
and rat embryonic tissue and adult and embryonic mouse tissue.
Experiment 10, E-GEOD-29963 provided samples from specific
cell types (spermatocytes and round spermatids) and was selected
to compare coexpression patterns in these cells and to compare
these results with those observed in whole testis tissue. Of the total
137 genes selected for our enriched geneset, all were available on
the mouse microarray platform, 136 were available on human and
122 on the rat microarrays.
Microarray data normalization
Affymetrix CEL files were downloaded from ArrayExpress and
normalised using the robust multiarray average (RMA) algorithm
[38] available in the affy package of Bioconductor [39]. For each
experiment box plots of samples across all probes showed the
arrays to be similarly distributed and controls clustered separately
from exposed samples. Affymetrix chip annotation databases were
used for probe to gene mapping. For reporting purposes, where
different synonyms were used for histone demethylases they were
converted to the recent nomenclature standard for these genes
[40]. For example, the gene symbol Utx, used in the human and
rat annotation packages, was converted to the new nomenclature
Kdm6a. Where more than one probe was available for a gene the
probe with the highest average expression across normal samples
was selected for each biological setting.
Differential expression analysis
Statistical analyses were carried out using Bioconductor within
the R statistical software environment [38]. Differential expression
was determined using the lmFit and eBayes functions available in
the limma package [41]. The lmFit function was used to fit a linear
model for each gene in the geneset allowing estimation of the
coefficient comparing controls and each compound exposed
group. The eBayes function was then used to compute moderated
t-statistics and p-values for the coefficient estimates from lmFit.
The p-values were adjusted for multiple testing using the
Benjamini & Hochberg method [42]. Genes differentially
expressed by a fold change greater than or equal to 1.5 and an
adjusted p-value less than 0.05 are reported. A relatively modest
fold change cut-off point was selected since the histone modifying
genes, the focus of this study, are known to be tightly regulated and
small differences are likely to have biological relevance.
Coexpression analysis
Fundamental to this work was the hypotheses that genes with
similar expression profiles were likely to have coactivity or be
functionally influenced by each other. In 2004 Allocco et al [43]
tested the similar hypothesis that genes with similar expression
profiles are likely to be regulated by the same mechanisms and
showed that genes with a correlation between their expression
profiles above 0.84 have a greater than 50% chance of sharing a
common transcription factor binder site. Here, Pearson correla-
tion coefficients (r) were calculated and an absolute-value threshold
of 0.75, p-value,0.05, was used to detect coexpression patterns
between each gene and all others in the analysis set. A lower
threshold than that used by Allocco was selected as the
coregulatory relationships we aimed to investigate were broader
in nature than the more targeted objective of the Allocco study.
The samples from experiment 1 were pooled from several cell
types and in Experiment 4 samples from three generations were
grouped as either exposed or non-exposed. Partial correlation was
used to calculate the Pearson correlation for these experiments to
take into account the sample and generation groupings. Partial
correlation was also applied for the analysis of Experiments 7–9
where samples from different time points were grouped to provide
sufficient samples sizes for coexpression analysis.
Supporting Information
Figure S1 Ingenutiy Pathway Analysis (IPA) network of
ASCOM components. Network showing interactions between
histone modifier proteins: gene identifiers for the geneset were
uploaded into the IPA application. Each identifier was mapped to
its corresponding object in the IngenuityH Knowledge Base. A
core analysis was conducted that generated networks of molecules
based on their connectivity. The most comprehensive of which is
shown. Connections between molecules are based on information
contained in the Ingenuity Knowledge base and represent at least
nine publications reporting molecule interactions in a range of
non-testis tissues and cell types.
(PDF)
Table S1 Analysis geneset.
(PDF)
Table S2 Conserved coexpression across species and in
experiments in rat.
(PDF)
Table S3 Conserved coexpression in mouse.
(PDF)
Table S4 Data sources.
(PDF)
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